Physical function and symptoms in children with cystic fibrosis
Official title: Comparison of Dyspnea, Functional Capacity, Muscle Strength, Urinary Incontinence and Quality of Life Between Children and Adolescents With Cystic Fibrosis and Healthy Children
Run by Izmir Democracy University · NCT06984679 · Data updated 2026-11-12
This project will compare breathing difficulty, exercise capacity, muscle strength, bladder control, and quality of life in children aged 6–18 with cystic fibrosis versus healthy peers to see where support is needed.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 18 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Izmir Democracy University Academic / other |
| Locations | 1 site (Izmir) |
| Status | Recruiting |
| Started | September 15, 2025 |
| Main results expected | March 1, 2027 |
| Study ends | March 3, 2027 |
| Registry record updated | March 27, 2026 |
| Trial ID | NCT06984679 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and adolescents aged 6–18 with a confirmed diagnosis of cystic fibrosis who are clinically stable for at least three weeks and able to cooperate with testing are ideal candidates.
✕Probably not a fit
Children who are not clinically stable, have recent orthopedic, neurological, psychological, or cardiovascular problems, cannot cooperate with tests, or are current/former smokers are unlikely to be included or to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study compares dyspnea, functional capacity, muscle strength, urinary incontinence, and quality of life between children and adolescents with cystic fibrosis and age- and gender-matched healthy peers. Participants aged 6–18 will undergo clinical evaluations, exercise tests, physical measurements, and standardized questionnaires. Data will be collected at Izmir Democracy University and analyzed to identify differences in physical impairments and symptom burden. Results are intended to inform health management and rehabilitation priorities for children with cystic fibrosis.
Why it matters
Potential benefit: If successful, the findings could identify specific physical or symptom areas to target with therapy and rehabilitation to improve daily functioning and quality of life for children with CF.
How similar studies have gone: Previous observational studies have reported reduced exercise capacity and muscle strength in children with CF and have helped guide rehabilitation, so the basic approach is established though local data may be limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Children and Adolescents with Cystic Fibrosis: * To be between the ages of 6-18 * To have been diagnosed with cystic fibrosis * To be clinically stable for at least 3 weeks * To have the necessary cooperation for the measurements * To volunteer to participate in the study Inclusion Criteria for Healthy Children and Adolescents: * To be between the ages of 6-18 * To be in a similar average and ratio with the group of children and adolescents with cystic fibrosis in terms of age and gender * To have the necessary cooperation for the measurements * To volunteer to participate in the study Exclusion Criteria for Children and Adolescents with Cystic Fibrosis: * Having any orthopedic, neurological, psychological or cardiovascular problem that may prevent the measurements from being performed in the last 6 months * Smoking or quitting smoking Exclusion Criteria for Healthy Children and Adolescents: * Having any orthopedic, neurological, psychological or cardiovascular problem that may prevent the measurements from being performed in the last 6 months * Having any chronic disease * Smoking or quitting smoking
Where it's running
-
Izmir Democracy University
Izmir, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Yağmur Külekçi, PT — Izmir Democracy University
- Study coordinator: Gülşah Barğı, Assoc Prof
- Email: gulsahbargi35@gmail.com
- Phone: +90 232 299 0739
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oropharyngeal suction and physiotherapy to detect lung bacteria in kids with chronic lung disease
A randomized study will test whether taking samples from the throat with suction, with or without prior physiotherapy, can reliably detect bacteria in children 5–18 with chronic lung disease, compared with standard sample methods.
-
Seeing if CFTR functioncan be restored in CF through patient cells with rare mutations
This study tests whether testing a patient’s own nasal cells in the lab can predict if CFTR-modulator therapies might help people with uncommon CF mutations.
-
Perceptions and Intentions Around a Change in CF Treatment
This study asks adults with cystic fibrosis currently on ETI whether they would switch to VTD if their doctor offered it and what factors influence that decision.
-
How the CF medicines elexacaftor, tezacaftor, and ivacaftor behave in the body
This study tests how the CF medicines elexacaftor, tezacaftor, and ivacaftor move through the body in patients with cystic fibrosis who are already taking the combination therapy.
-
Autogenic Drainage vs. Mechanical Chest Percussion in Children with Cystic Fibrosis
In children aged 6-12 with cystic fibrosis, this study tests whether autogenic drainage helps lung function and comfort more than mechanical percussion.
-
Pharmacokinetics of Antibiotics in CF Patients on ETI
This study tests how antibiotics behave in the body of people with cystic fibrosis who are taking the ETI modulator therapy and are being treated for a pulmonary infection.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.